L408 (Darifenacin Hydrobromide Extended-Release 7.5 mg)
Pill with imprint L408 is White, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Alembic Pharmaceuticals Inc.
Darifenacin is used in the treatment of overactive bladder; urinary frequency; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L408

Darifenacin Hydrobromide Extended-Release
- Imprint
- L408
- Strength
- 7.5 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alembic Pharmaceuticals Inc.
- Manufacturer
- Alembic Pharmaceutical Limited
- National Drug Code (NDC)
- 62332-0223
- Inactive Ingredients
-
hypromelloses,
povidone k30,
calcium phosphate dibasic anhydrous,
magnesium stearate,
titanium dioxide,
polyethylene glycol 1500,
magnesium silicate
Note: Inactive ingredients may vary.
Related images for "L408"
More about darifenacin
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (25)
- Drug images
- Pricing & coupons
- En español
- Drug class: urinary antispasmodics
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.